Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation
Ziad Hijazi, Senior Medical Director at Thermo Fisher Scientific, shared a post on LinkedIn about a recent article by Maria Tomasdottir et al, published in BMJ journals, adding:
“Refining risk assessment in atrial fibrillation without oral anticoagulation
Our new study shows that NT-proBNP provides important prognostic information in patients with AF not receiving anticoagulation, irrespective of presenting rhythm.
The findings strengthen the evidence underpinning biomarker-based risk stratification in this important but less-studied AF population, with relevance for clinical risk assessment and for patient characterization and enrichment strategies in clinical trials.
Proud to see this work by our PhD student Maria Tomasdottir at Uppsala University published in Heart.”
Title: NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation
Authors: Maria Tomasdottir, Jonas Oldgren, Johan Lindbäck, Alexander Benz, John W Eikelboom, Agneta Siegbahn, Lars Wallentin
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis